# FDA Inspection 1062666 - AstraZeneca Pharmaceuticals LP - August 17, 2018

Source: https://www.keypedia.com/records/fda_inspections/astrazeneca-pharmaceuticals-lp/e8cc1fea-3abb-4c6e-ba1a-26aa0b81097f
Source feed: FDA_Inspections

> FDA Inspection 1062666 for AstraZeneca Pharmaceuticals LP on August 17, 2018. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1062666
- Company Name: AstraZeneca Pharmaceuticals LP
- Inspection Date: 2018-08-17
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1197584 - 2023-01-19](https://www.keypedia.com/records/fda_inspections/astrazeneca-pharmaceuticals-lp/8f38115c-8fc4-487e-a8a4-911759c96220)
- [FDA Inspection 936980 - 2015-07-24](https://www.keypedia.com/records/fda_inspections/astrazeneca-pharmaceuticals-lp/38f13f8b-b1dc-4dd9-92eb-01a857cfa3e2)
- [FDA Inspection 800093 - 2012-09-21](https://www.keypedia.com/records/fda_inspections/astrazeneca-pharmaceuticals-lp/fde08717-9676-4f37-ab61-6645a32e4d4b)
- [FDA Inspection 590281 - 2009-06-18](https://www.keypedia.com/records/fda_inspections/astrazeneca-pharmaceuticals-lp/107a5153-cd5b-43fa-942e-545e1967efd0)

Company: https://www.keypedia.com/companies/astrazeneca-pharmaceuticals-lp/6f9abb75-9352-43df-b761-026089396fa3

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c